Selenoprotein-p and insulin resistance in children and adolescents with obesity

Table 6 Multiple linear regression analysis for factors affecting selenoprotien P1 level in children with obesity (n = 85)

Variables1	B	95%CI	P value
DBP	-0.571	-1.313 to 0.171	0.129
Height (cm)	0.077	-2.640 to 2.794	0.955
Waist circumference (cm)	0.414	-4.348 to 5.176	0.863
BMI (kg/m2)	-0.542	-1.726 to 0.643	0.365
W/H ratio	33.413	-631.753 to 698.579	0.920
ALT (U/L)	-0.100	-0.467 to 0.267	0.589
AST (U/L)	-0.470	-1.005 to 0.066	0.085
Total Cholesterol (mg/dL)	-0.321	-0.526 to -0.117	0.003a
HDL (mg/dL)	-0.893	-1.835 to 0.049	0.063
LDL (mg/dL)	0.335	0.089 to 0.581	0.008a
Triglycerides (mg/dL)	0.163	0.016 to 0.309	0.030a
VAI	-8.340	-15.321 to -1.359	0.020a
Serum insulin (uIU/mL)	1.295	0.443 to 2.146	0.003a
HOMA-IR	-6.224	-9.685 to -2.764	0.001a

¹Every variable was adjusted for other variables in the table.

^aP < 0.05.

B: Regression coefficient. ALT: Alanine transaminase; AST: Aspartate aminotransferase; BMI: Body mass index; DBP: Diastolic blood pressure; DM: Diabetes mellitus; FBS: Fasting blood sugar; HDL: High-density lipoprotein; HOMA-IR: Homeostasis Model Assessment insulin resistance; HTN: Hypertension; IQR: Interquartile range (25^th–75^th percentiles); LDL: Low-density lipoprotein; SEPP1: Selenoprotien P1; VAI: Visceral adiposity index, W/H ratio: Waist/height ratio.